NasdaqCM - Delayed Quote USD

Moolec Science SA (MLEC)

Compare
0.8500 -0.0100 (-1.16%)
At close: 4:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
Total Revenue
5,625.1240
5,625.1240
905.0490
--
Cost of Revenue
5,152.5430
5,152.5430
1,048.3540
--
Gross Profit
472.5810
472.5810
-143.3050
--
Operating Expense
9,515.4320
9,515.4320
49,215.5610
3,652.4330
Operating Income
-9,042.8510
-9,042.8510
-49,358.8660
-3,652.4330
Net Non Operating Interest Income Expense
287.1650
287.1650
536.3170
-2.1300
Other Income Expense
396.4410
396.4410
-3,200.8730
-872.3420
Pretax Income
-8,359.2450
-8,359.2450
-52,023.4220
-4,526.9050
Tax Provision
-1,046.9850
-1,046.9850
-234.5420
--
Net Income Common Stockholders
-7,312.2600
-7,312.2600
-51,788.8800
-4,526.9050
Diluted NI Available to Com Stockholders
-7,312.2600
-7,312.2600
-51,788.8800
-4,526.9050
Basic EPS
-0.19
--
-1.50
-0.12
Diluted EPS
-0.19
--
-1.50
-0.12
Basic Average Shares
37,870.3510
--
34,466.2580
37,560.2490
Diluted Average Shares
37,870.3510
--
34,466.2580
37,560.2490
Total Operating Income as Reported
-9,042.8510
-9,042.8510
-6,653.8050
-3,652.4330
Total Expenses
14,667.9750
14,667.9750
50,263.9150
3,652.4330
Net Income from Continuing & Discontinued Operation
-7,312.2600
-7,312.2600
-51,788.8800
-4,526.9050
Normalized Income
-7,659.0473
-7,659.0473
-48,602.4378
-3,654.5630
Interest Income
1,386.0520
1,386.0520
693.0270
--
Interest Expense
1,165.4180
1,165.4180
160.0350
2.1300
Net Interest Income
287.1650
287.1650
536.3170
-2.1300
EBIT
-7,193.8270
-7,193.8270
-51,863.3870
-4,524.7750
EBITDA
-6,179.6660
-6,179.6660
-51,741.3650
-4,523.0760
Reconciled Cost of Revenue
4,721.2780
4,721.2780
1,023.2570
--
Reconciled Depreciation
1,014.1610
1,014.1610
122.0220
1.6990
Net Income from Continuing Operation Net Minority Interest
-7,312.2600
-7,312.2600
-51,788.8800
-4,526.9050
Total Unusual Items Excluding Goodwill
396.4410
396.4410
-3,200.8730
-872.3420
Total Unusual Items
396.4410
396.4410
-3,200.8730
-872.3420
Normalized EBITDA
-6,576.1070
-6,576.1070
-48,540.4920
-3,650.7340
Tax Rate for Calcs
0.0001
0.0001
0.0000
--
Tax Effect of Unusual Items
49.6537
49.6537
-14.4308
--
6/30/2022 - 3/2/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KRBP Kiromic BioPharma, Inc.
0.9201
+0.01%
 
GDTC CytoMed Therapeutics Limited
2.5600
+3.64%
 
OKYO OKYO Pharma Limited
1.0600
-2.75%
 
NNBP Nanobac Pharmaceuticals, Incorporated
0.0001
0.00%
 
NV4.MU Cellectar Biosciences Inc
0.2380
-4.03%
 
LIDDS.ST LIDDS AB (publ)
0.1045
-0.95%
 
NANECH.ST NanoEcho AB
0.1580
+21.54%
 
QUIA.ST Quia Pharma AB (publ)
0.0172
+3.61%
 
COMBI.ST CombiGene AB (publ)
2.7200
+5.43%
 
AKTX Akari Therapeutics, Plc
0.9700
-3.00%